Cardiometabolic – Medgate Today

Home / Posts Tagged "Cardiometabolic"

Lilly’s tirzepatide superior to semaglutide in head-to-head trial showing an average weight loss of 20.2% vs. 13.7%

December 6, 2024

6:15 am

Participants using tirzepatide lost 22.8 kg and participants on semaglutide lost 15.0 kg SURMOUNT-5 compared tirzepatide, a dual GIP and GLP-1 receptor agonist, to semaglutide, a mono GLP-1 receptor agonist in adults living with obesity without diabetes Eli Lilly and Company (NYSE: LLY) today announced topline results

POST TAGS:

Women and Heart Health: Insights from Dr. Balbir Singh and Dr. Anupam Goel on Unique Risks and Outcomes

October 29, 2024

9:56 am

Doctor Speaks Expert views News Update

admin

Cardiovascular disease is the leading cause of mortality in women and mortality rate has remained greater for women (than men); but till recently risk of CAD and MI was not considered real specially in younger women. However, over the last decade, there have been marked reductions

POST TAGS:

American Heart Association CAD Cardiometabolic Cardiovascular disease Director of Interventional Cardiology Dr Balbir Singh Dr. Anupam Goel Dyslipidemia Inflammatory diseases Max hospital menopause MI PCI rheumatoid SLE STEMI

Lilly’s tirzepatide superior to semaglutide in head-to-head trial showing an average weight loss of 20.2% vs. 13.7%

POST TAGS:

Women and Heart Health: Insights from Dr. Balbir Singh and Dr. Anupam Goel on Unique Risks and Outcomes

POST TAGS:

FIND US

ADDRESS

FOLLOW US ON SOCIAL MEDIA